Eun Mi Lee

Title: Eun Mi Lee: Innovator in Molecular Diagnostics

Introduction

Eun Mi Lee is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of molecular diagnostics, holding a total of 4 patents. Her work focuses on innovative methods for detecting and genotyping viruses, which are crucial for public health.

Latest Patents

One of her latest patents is an isothermal transcription-based assay for the detection and genotyping of the dengue virus. This assay utilizes primer combinations for sequences within the envelope gene or the 3′ non-coding region of the virus, along with specific probes for different serotypes of the dengue virus. Another notable patent is the CCR5 RNA transcription-based amplification assay, which includes a method and test kit for genotyping the CCR5 chemokine receptor. This method amplifies CCR5 transcript DNA using transcription-based amplification, and the amplification product is detected through hybridization with labeled oligonucleotide probes.

Career Highlights

Eun Mi Lee is currently employed at Akzo Nobel N.V., where she continues to advance her research in molecular diagnostics. Her innovative approaches have positioned her as a key figure in her field.

Collaborations

Eun Mi has collaborated with notable colleagues, including Gregory J Hurteau and Joseph W Romano, contributing to the advancement of their shared research goals.

Conclusion

Eun Mi Lee's work in molecular diagnostics exemplifies the impact of innovative thinking in addressing health challenges. Her patents reflect her commitment to improving detection methods for critical viruses, showcasing her role as a leading inventor in this vital area.